Zhang YL 1996.
Methods | Country: China Setting: outpatients and inpatients Aim: to observe the effects of TPF capsule in the treatment of senile osteoporosis Study design: randomised controlled trial Analysis: T‐test Loss to follow‐up: not reported |
|
Participants | Ethnicity: Chinese 120 senile osteoporosis patients enrolled: 60 in trial group, 60 in control group Inclusion criteria: WHO diagnostic criteria for osteoporosis based on bone density levels, BMD detected by SPA Exclusion criteria: not mentioned |
|
Interventions | Experimental: TPF capsule, 3 to 4 capsules, 3 times a day, for 6 months Control: calcium granule, 10 g, twice a day, for 6 months |
|
Outcomes | BMD, ALP | |
Notes | No funding sources or declarations of interest for the primary researchers reported | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Adequate sequence generation | Unclear risk | No information provided |
Allocation concealment | Unclear risk | No information provided |
Blinding All outcomes | Unclear risk | Insufficient information to permit judgement of 'low risk' or 'high risk' |
Incomplete outcome data addressed All outcomes | Low risk | No missing outcome data |
Free of selective reporting | Unclear risk | Not all the outcomes that were of interest in this review were reported |
Free of other bias | Unclear risk | P value for the baseline comparison not stated |